Table 3.
OR | 95% CI | |
---|---|---|
Male gender | 2.20 | 1.55 - 3.10* |
Serum Lactate >6.2 (mm/L) 0-6 hrs. | 2.05 | 1.49 - 2.81* |
APACHE II >33 | 2.07 | 1.49 - 2.88* |
Vasopressor utilization 0-24 hrs. | 2.08 | 1.49 - 2.89* |
PRBC administration >9.5 (U) 0-12 hrs. | 2.06 | 1.44 - 2.94* |
NISS >34 | 1.83 | 1.36 - 2.49* |
BMI >28 | 1.60 | 1.20 - 2.14* |
Comorbidity: Liver disease | 2.52 | 1.32 - 4.81* |
Comorbidity: Diabetes | 1.14 | 0.74 - 1.77 |
Comorbidity: COPD | 1.69 | 0.89 - 3.22 |
FFP administration >7.8 (U) 0-12 hrs. | 1.14 | 0.74 - 1.77 |
OR - Robust Odds Ratio estimates, CI - confidence interval, (U) - Units, PRBC - packed red blood cells, FFP - fresh frozen plasma, NISS - New injury severity score, BMI - Body mass index, COPD - Chronic obstructive pulmonary disease,
p<0.05